A1 vs A2 Milk: How Beta-Casein Type Affects Opioid Peptide Release and Human Health

A1 and A2 beta-casein variants release different amounts of the opioid peptide beta-casomorphin-7 during digestion, with A1 casein (BCM-7 releasing) potentially linked to health effects including GI discomfort and immune modulation.

Kamiński, Stanisław et al.·Journal of applied genetics·2007·Preliminary EvidenceReview
RPEP-01249ReviewPreliminary Evidence2007RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

A1 beta-casein releases more beta-casomorphin-7 (BCM-7) during digestion than A2, with BCM-7 showing opioid, immunomodulatory, and GI effects that may explain the health differences attributed to A1 versus A2 milk consumption.

Key Numbers

How They Did This

review study on opioid-peptides, bioactive-food-peptides.

Why This Research Matters

Relevant for opioid-peptides, bioactive-food-peptides.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding A1 beta-casein releases more beta-casomorphin-7 (BCM-7) during digestion than A2, with BCM-7 showing opioid, immunomodulatory, and GI effects that may
Evidence Grade:
preliminary evidence.
Study Age:
Published in 2007.
Original Title:
Polymorphism of bovine beta-casein and its potential effect on human health.
Published In:
Journal of applied genetics, 48(3), 189-98 (2007)
Database ID:
RPEP-01249

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

What was studied?

A1 vs A2 Milk: How Beta-Casein Type Affects Opioid Peptide Release and Human Health

What was found?

A1 and A2 beta-casein variants release different amounts of the opioid peptide beta-casomorphin-7 during digestion, with A1 casein (BCM-7 releasing) potentially linked to health effects including GI discomfort and immune modulation.

Read More on RethinkPeptides

Cite This Study

RPEP-01249·https://rethinkpeptides.com/research/RPEP-01249

APA

Kamiński, Stanisław; Cieslińska, Anna; Kostyra, Elzbieta. (2007). Polymorphism of bovine beta-casein and its potential effect on human health.. Journal of applied genetics, 48(3), 189-98.

MLA

Kamiński, Stanisław, et al. "Polymorphism of bovine beta-casein and its potential effect on human health.." Journal of applied genetics, 2007.

RethinkPeptides

RethinkPeptides Research Database. "Polymorphism of bovine beta-casein and its potential effect ..." RPEP-01249. Retrieved from https://rethinkpeptides.com/research/kaminski-2007-polymorphism-of-bovine-betacasein

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.